A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Lupus Nephritis
Related studies linked through entity extraction aliases.
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CHT105 for the Treatment of Refractory Lupus Nephritis
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Anti-alpha-actinin Antibodies and Lupus Nephritis Activity
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Therapeutic Drug Monitoring of Mycophenolate Mofetil in Lupus Nephritis
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
- Status
- RECRUITING
- Phase
- PHASE4
UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE1
LUPKYNIS Drug-use Results Survey
- Status
- RECRUITING
- Phase
- N/A
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus With Active Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of the Tolerance, Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of MIL62 Injection for Treating Lupus Nephritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.
- Status
- COMPLETED
- Phase
- N/A
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
- Status
- RECRUITING
- Phase
- PHASE2
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- Status
- RECRUITING
- Phase
- PHASE1
Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children
- Status
- RECRUITING
- Phase
- PHASE3
Systemic Immune Inflammatory Index in Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- N/A
CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis
- Status
- RECRUITING
- Phase
- EARLY_PHASE1